A protein bispecific composed of a human IgG4-Fc domain displaying an antagonistic anti-human MAdCAM-1 single chain (sc)-Fv and a human interleukin (IL-)22 provides a localized dual-mechanism strategy for restoring intestinal immune homeostasis.
RCD is proposed as a failure of innate immune regulation rather than solely as an adaptive response, viewing RCD as a failure of innate immune regulation rather than solely as an adaptive response.
Sara Shaikh, Preeti Jain· Frontiers in Immunology· 0 citations
Gastrointestinal (GI) adenocarcinomas pose a significant therapeutic challenge due to highly immunosuppressive tumor microenvironments that limit effective antitumor immune responses. Dense stromal fibrosis, immune exclusion and poor responses to immune checkpoint inhibitors are hallmarks of treatment-resistant maligna...
Neeraj Choudhary, M. Faiyazuddin, R. Kamal et al.· Cancer Letters· 0 citations
In parallel, CAR regulatory T cells (CAR Tregs) may offer a complementary approach for IBD therapy by redirecting suppressive immune function in the inflamed intestine and provide a mechanistically attractive strategy to modulate T helper–type 17-driven mucosal inflammation in CD.
BACKGROUND
Systemic lupus erythematosus (SLE) is a multi-organ autoimmune disease. B cells play a crucial role in disease initiation and progression. Clinical trial evidence suggests that intensified B-cell depletion can improve SLE therapeutic outcomes. While efficacy and tolerability of belimumab, the first B-cell-ta...
Xiwei Feng, Di Long, Huiqi Yin et al.· Arthritis & Rheumatology· 0 citations
We use cookies to run the site and, with your consent, for analytics and to show ads.
See our Cookie Policy.